home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Patient-Specific Cancer Treatment

  August, 31 2006 6:24
your information resource in human molecular genetics
Scientists have discovered a way to cause some cancerous cells to self-destruct. These findings, reported in the October 2006 issue of Nature Chemical Biology, describe the use of a small molecule to 'wake up' the key enzyme -- caspase-3 -- that causes cell death.

Caspase-3 normally exists as a proenzyme, meaning that further processing is required to make the final, active enzyme. This processing is normally performed by other caspases and serves as a signal that something has gone wrong with a cell; it signals that cell death or 'apoptosis' is desired. Paul Hergenrother and colleagues have now used the synthetic compound PAC-1 to trick procaspase-3 into processing itself, generating caspase-3 and causing cell death. They demonstrated, in a variety of cancer cell types, that cell death is correlated with the amount of procaspase-3 present in the cells, with more procaspase-3 resulting in cell death at lower concentrations of PAC-1, while healthy cells remain unaffected.

The variability of procaspase-3 levels in the cell lines tested means that some patients would be more responsive to this therapy than others. As such, this research potentially offers a novel opportunity for individualized cancer therapy.

Author contact:

Paul J Hergenrother (The University of Illinois, Urbana, IL, USA)
E-mail: hergenro@uiuc.edu

Abstract available online.

(C) Nature Chemical Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.